Evidence map›Paper›PMID 24656046›Full record

ArticleImmunity2014

Noncanonical NF-κB pathway controls the production of type I interferons in antiviral innate immunity.

Jin Jin, Hongbo Hu, Haiyan S Li, Jiayi Yu, Yichuan Xiao, George C Brittain, Qiang Zou, Xuhong Cheng, Frédérick A Mallette, Stephanie S Watowich and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 139 citations in OpenAlex.

  1. Effect of high-doseFrontiers in immunology · 2024
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Transcriptomic Differences Between Immortalized Oral and Skin Keratinocytes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  11. Dendritic cell maturation in cancer.Nature reviews. Cancer · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Targeting chromosomal instability in patients with cancer.Nature reviews. Clinical oncology · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Jin JinDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Hongbo HuDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Haiyan S LiDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Jiayi YuDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Yichuan XiaoDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
George C BrittainDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Qiang ZouDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Xuhong ChengDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Frédérick A MalletteDepartment of Medicine, University of Montreal, Montreal, QC H1T 2M4, Canada.
Stephanie S WatowichDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030, USA.
Shao-Cong SunDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030, USA. Electronic address: ssun@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USUniversité de Montréal · CA

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kathrin Milbury · 1985 to 2026
$290.8M
TpI2 Kinase in Macrophage Activation by MicrobesR01AI057555 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SUN, SHAO-CONG · 2004 to 2021
$6.7M
Molecular Studies of Noncanonical NF-kb SignalingR01GM084459 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SUN, SHAO-CONG · 2008 to 2021
$4.4M
Signaling Functions of the Tumor Suppressor CYLDR01AI064639 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SUN, SHAO-CONG · 2006 to 2014
$3.6M
Regulation of T-cell function and autoimmune inflammation by deubiquitinases.R37AI064639 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SUN, SHAO-CONG · 2015 to 2021
$2.8M
Signaling functions of Peli family of E3 ubiquitin ligasesR01AI104519 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SUN, SHAO-CONG · 2013 to 2017
$2.1M
NCI NIH HHS P30 CA016672NCI NIH HHS P30CA016672NIAID NIH HHS AI057555NIAID NIH HHS AI064639NIAID NIH HHS AI104519NIAID NIH HHS R01 AI057555NIAID NIH HHS R01 AI064639NIAID NIH HHS R01 AI104519NIAID NIH HHS R37 AI064639NIGMS NIH HHS GM84459NIGMS NIH HHS R01 GM084459
6 · The paper itself

Abstract

Production of type I interferons (IFN-I) is a crucial innate immune mechanism against viral infections. IFN-I induction is subject to negative regulation by both viral and cellular factors, but the underlying mechanism remains unclear. We report that the noncanonical NF-κB pathway was stimulated along with innate immune cell differentiation and viral infections and had a vital role in negatively regulating IFN-I induction. Genetic deficiencies in major components of the noncanonical NF-κB pathway caused IFN-I hyperinduction and rendered cells and mice substantially more resistant to viral infection. Noncanonical NF-κB suppressed signal-induced histone modifications at the Ifnb promoter, an action that involved attenuated recruitment of the transcription factor RelA and a histone demethylase, JMJD2A. These findings reveal an unexpected function of the noncanonical NF-κB pathway and highlight an important mechanism regulating antiviral innate immunity.

Indexed as

Immunity, InnateAnimalsCell DifferentiationDendritic CellsEnzyme ActivationFemaleGene Expression RegulationHematopoietic Cell Growth FactorsHistone DemethylasesHistonesInterferon-betaInterferon Type ILigandsMiceNF-kappa BNF-kappaB-Inducing KinaseHematopoietic Cell Growth FactorsHistone DemethylasesHistonesInterferon-betaInterferon Type IJMJD2A protein, mouseLigandsNF-kappa BNF-kappaB-Inducing KinaseProtein Serine-Threonine KinasesToll-Like ReceptorsTranscription Factor RelA

Identifiers

PMID24656046
PMCPMC3983709
OpenAlexW2005626121

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.